WinstonWınston
Danone S.A. logo

Danone S.A.

DANOY
51
Packaged Foods · Consumer Defensive
Price
$16.61
-0.06 (-0.36%)
Market Cap
$53.33B
Exchange
Other OTC
Winston Score
51
Winston is curious
Mixed quality — meaningful strengths and weaknesses.

Danone is a French food and beverage company that makes products people eat and drink every day. Its three main businesses are dairy and plant-based foods (like Activia yogurt and Alpro), specialized nutrition (baby formula and medical nutrition products), and bottled water (Evian and Volvic). It sells to grocery stores, pharmacies, and hospitals in over 120 countries.

Danone earns money by selling packaged goods at retail, with pricing power supported by well-known brands and a strong position in the specialized nutrition market — particularly infant formula, where trust and regulation create high switching costs. The company generates roughly €27 billion in annual revenue, with significant exposure to Europe and emerging markets like China and Latin America. A key risk is ongoing pressure in the infant nutrition segment, where birth rate declines in China have reduced demand, and competition from local brands continues to intensify.

Winston Score History

Share count broadly stable

0.2% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 3.23B (2021) → 3.23B (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
50.3%
Healthy — 50.3% gross margin
Operating Margin
10.1%
Modest — 10.1% operating margin
ROCE
4.5%
Weak — 4.5% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-1.1%
Shrinking sales (-1.1% YoY)
EPS YoY
+108.8%
Earnings growing fast (108.8% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
200%
Turns 200% of profit into real cash
FCF Margin
10.4%
Modest free cash flow (10.4%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.80
Moderate — manageable debt (0.80)
Interest Cover
7.65x
Adequate interest coverage (7.7x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
14.0x
Attractive valuation — P/E 14.0

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward
-5.1
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
3.07%
Moderate income — 3.07% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
+6.3%
Dividend growing modestly (6.3% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial